The Philippines has one of the highest TB burdens in the world—and 2.6% of its more than 286,000 new cases in 2015 were of multi-drug-resistant TB (MDR-TB). This threatens the progress the country has made in addressing the deadly disease over the past few decades and its goal to make the country TB-free by 2030. […]
The training materials in this compilation were developed by technical advisors from SIAPS. The training was conducted in November 2014. This will serve as a guide for trainings in LIMU. Sessions follow the spectrum of information management from data organization, analysis, and interpretation to the utilization of information for information sharing, planning, and decision making. A stakeholder analysis, which is important to prepare and disseminate audience-specific reports, is also included.
The user guide primarily serves as a reference in reporting an adverse event (AE) through PViMS. It also serves to guide reporters and investigators in completing a correct and accurate AE report. This guide outlines the key data needed, starting from the initial alert to the completion of an AE report in PViMS.
The concept of a Barangay Health Management Council (BHMC) was developed by a working group comprising technical advisors from SIAPS and health staff from the Quezon City Health Department in late 2011. The BHMC initiative aims to strengthen the delivery of services under the national tuberculosis (TB) control program (NTP) in poor urban communities. This document was developed as a quick reference for those who plan to establish BHMCs. The contents of this guide are based on the insights and experiences of the people involved in the implementation of the BHMC initiative in Quezon City from 2012 to 2016. Described here are the practical steps for establishing, operationalizing, and sustaining a BHMC.
This document is a compilation of the training materials used for the course entitled “Enhanced TB Microscopy Training of Trainers.” The course was held on July 25 to 29, 2016, at the Cebu TB Reference Laboratory in Cebu City, Philippines, and is part of the activities under the National TB Program (NTP) Laboratory Training Decentralization Strategy. This training of trainers (TOT) was planned, organized, and implemented jointly by SIAPS/PH, the National TB Reference Laboratory (NTRL), and the Department of Health (DOH) Regional Office for Central Visayas. The materials for this course were designed so that they can be used in the original or modified version in future TOTs for TB microscopy or for other NTP laboratory training. Trainers from the NTP will benefit from these materials as they will find them useful when they plan and conduct future trainings.
In the Philippines, tuberculosis (TB) is the sixth leading cause of death, mostly affecting the poor and vulnerable populations. Stock-outs of TB medicines in public health facilities compromise treatment of patients with TB because of limited access and additional burden of out-of-pocket expenses for medicines. As part of the improvement of the overall supply chain of the TB program, SIAPS has been working with the Department of Health central office with focus on quantification, procurement, storage, distribution, and pharmacovigilance. In addition, the National TB Control Program (NTP) requested SIAPS to develop an action-oriented practical guide for TB pharmaceutical management.
Implementing QuanTB to Improve Forecasting, Supply Planning, and Early Warning Systems for TB Medicines: Philippines Report
SIAPS conducted an evaluation of its TB technical assistance and the QuanTB implementation in Philippines. Specific objectives were to determine:
- Key achievements or results of SIAPS QuanTB technical assistance in Philippines
- Experiences and perspectives of the beneficiaries from the NTP
- Challenges and lessons learned
This report summarizes key aspects and results of the analysis for Philippines.
The Economic Cost of Non-Adherence to TB Medicines Resulting from Stock-Outs and Loss to Follow-Up in the Philippines
A key element of successful tuberculosis (TB) control programs is adherence to treatment. Non-adherence results in increased length and severity of illness, death, disease transmission, and drug resistance. The purpose of this study was to estimate the morbidity and mortality impact and economic costs of non-adherence to TB medicines resulting from treatment interruption due to stock-outs or loss to follow-up (LTFU).
Technical Brief: Building Leadership and Governance in Supply Chain Management for the National TB Control Program of the Philippines
The National TB Control Program (NTP) in the Philippines is continuously scaling up its operations in the diagnosis and treatment of TB to achieve the results and deliverables described in the 2010–2016 Philippine Plan of Action to Control Tuberculosis. The USAID-funded SIAPS Program is supporting the NTP in its effort to increase the capacity of various aspects of supply chain management, including leadership and governance. SIAPS supported the NTP in establishing the Drugs and Supplies Management Working Group by developing the terms of reference and facilitating regular meetings with partners and stakeholders.
Safety of Medicinal Products in the Philippines: Assessment of the Pharmacovigilance System and its Performance
The Food and Drug Administration (FDA) Philippines, with support from the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program conducted an assessment of the Philippines’ pharmacovigilance (PV) system and its components. They are (1) governance, policy, law, and regulation; (2) systems, structures, and stakeholder coordination; (3) signal generation and data management; (4) risk assessment and evaluation; and (5) risk management and communication, using the Indicator-based Pharmacovigilance Assessment Tool.
To learn more about SIAPS program activities worldwide, please read our annual report for program year 6.
Project dates: January 2012 – September 2017
A presentation by Mohan P. Joshi, Principal Technical Advisor and Lead for Pharmaceutical Services, SIAPS, at USAID in Arlington, VA […]